Polyphenon-E encapsulated into chitosan nanoparticles inhibited proliferation and growth of Ehrlich solid tumor in mice

References

• M.PrabaharanChitosan-based nanoparticles for tumor-targeted drug deliveryInt J Biol Macromol72201513131322
   PubMed Web of Science ®Google Scholar
• I.A.SiddiquiV.M.AdhamiD.J.BharaliB.B.HafeezM.AsimS.I.Khwajaet al.Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res69200917121716
   PubMed Web of Science ®Google Scholar
• I.A.SiddiquiD.J.BharaliM.NihalV.M.AdhamiN.KhanJ.C.Chamcheuet al.Excellent anti-proliferative and pro-apoptotic effects of (−)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivoNanomedicine10201416191626
   PubMed Web of Science ®Google Scholar
• M.PrabaharanReview paper: chitosan derivatives as promising materials for controlled drug deliveryJ Biomater Appl232008536
   PubMed Web of Science ®Google Scholar
• M.A.KhanM.ZafaryabS.H.MehdiI.AhmadM.M.RizviCharacterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancerInt J Biol Macromol932016242253
   PubMed Web of Science ®Google Scholar
• V.Zamora-MoraM.Fernandez-GutierrezA.Gonzalez-GomezB.SanzJ.S.RomanG.F.Goyaet al.Chitosan nanoparticles for combined drug delivery and magnetic hyperthermia: from preparation to in vitro studiesCarbohydr Polym1572017361370
   PubMed Web of Science ®Google Scholar
• A.DubeJ.A.NicolazzoI.LarsonChitosan nanoparticles enhance the plasma exposure of (−)-epigallocatechin gallate in mice through an enhancement in intestinal stabilityEur J Pharm Sci442011422426
   PubMed Web of Science ®Google Scholar
• M.HassanH.WatariA.AbuAlmaatyY.OhbaN.SakuragiApoptosis and molecular targeting therapy in cancerBiomed Res Int201415084
   Web of Science ®Google Scholar
• V.C.GeorgeG.DellaireH.P.RupasinghePlant flavonoids in cancer chemoprevention: role in genome stabilityJ Nutr Biochem452016114
   Web of Science ®Google Scholar
• E.LecumberriY.M.DupertuisR.MiralbellC.PichardGreen tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapyClin Nutr322013894903
   PubMed Web of Science ®Google Scholar
• N.KhanD.J.BharaliV.M.AdhamiI.A.SiddiquiH.CuiS.M.Shabanaet al.Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft modelCarcinogenesis352014415423
   PubMed Web of Science ®Google Scholar
• N.KhanH.MukhtarDietary agents for prevention and treatment of lung cancerCancer Lett3592015155164
   PubMed Web of Science ®Google Scholar
• N.YoshiokaY.HiasaM.ChoY.KitahoriK.HiraoN.Konishiet al.Effect of polyphenon-60 on the development of renal cell tumors in rats treated with N-ethyl-N hydroxyethylnitrosamineCancer Lett13619997982
   Web of Science ®Google Scholar
• A.SznarkowskaA.KosteckaK.MellerK.P.BielawskiInhibition of cancer antioxidant defense by natural compoundsOncotarget820171599616016
   PubMedGoogle Scholar
• F.RizziV.NaponelliA.SilvaA.ModernelliI.RamazzinaM.Bonaciniet al.Polyphenon E(R), a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosisCarcinogenesis352014828839
   Web of Science ®Google Scholar
• L.N.FixM.ShahT.EfferthM.A.FarwellB.ZhangMicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60Cancer Genomics Proteomics72010261277
   PubMedGoogle Scholar
• B.J.PhilipsC.H.CoyleS.N.MorrisroeM.B.ChancellorN.YoshimuraInduction of apoptosis in human bladder cancer cells by green tea catechinsBiomed Res302009207215
   PubMed Web of Science ®Google Scholar
• S.J.KimE.AmankwahS.ConnorsH.Y.ParkM.RinconH.Cornnellet al.Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP miceCancer Prev Res (Phila)72014435444
   Web of Science ®Google Scholar
• M.OzaslanI.D.KaragozI.H.KilicM.E.GuldurEhrlich ascites carcinomaAfr J Biotech10201123752378
   Web of Science ®Google Scholar
• S.VimalS.Abdul MajeedG.TajuK.S.NambiN.Sundar RajN.Madanet al.Chitosan tripolyphosphate (CS/TPP) nanoparticles: preparation, characterization and application for gene delivery in shrimpActa Trop1282013486493
   PubMed Web of Science ®Google Scholar
• M.M.TomaykoC.P.ReynoldsDetermination of subcutaneous tumor size in athymic (nude) miceCancer Chemother Pharmacol241989148154
   PubMed Web of Science ®Google Scholar
• J.F.EnsleyZ.MaciorowskiH.PietraszkiewiczG.KlemicM.KuKurugaS.Saparetoet al.Solid tumor preparation for flow cytometry using a standard murine modelCytometry81987479487
   Google Scholar
• R.S.RayB.GhoshA.RanaM.ChatterjeeSuppression of cell proliferation, induction of apoptosis and cell cycle arrest: chemopreventive activity of vanadium in vivo and in vitroInt J Cancer12020071323
   PubMed Web of Science ®Google Scholar
• W.S.JuanH.W.LinY.H.ChenH.Y.ChenY.C.HungS.H.Taiet al.Optimal Percoll concentration facilitates flow cytometric analysis for annexin V/propidium iodine-stained ischemic brain tissuesCytometry A812012400408
   PubMed Web of Science ®Google Scholar
• S.SinghS.PandeyA.N.BhattR.ChaudharyV.BhuriaN.Kalraet al.Chronic dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) inhibits the growth of implanted Ehrlich’s Ascites tumor in micePLoS ONE102015e0132089
   PubMed Web of Science ®Google Scholar
• J.LiangF.LiY.FangW.YangX.AnL.Zhaoet al.Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticlesColloids Surf B Biointerfaces822011297301
   PubMed Web of Science ®Google Scholar
• S.KumarR.MeenaP.RajamaniFabrication of BSA-green tea polyphenols-chitosan nanoparticles and their role in radioprotection: a molecular and biochemical approachJ Agric Food Chem64201660246034
   Web of Science ®Google Scholar
• H.l.ZhangSh.WuY.TaoLq.ZangZq.SuPreparation and characterization of water-soluble chitosan nanoparticles as protein delivery systemJ Nanomater20102010-1
   Google Scholar
• Y.ZhangN.KohlerM.ZhangSurface modification of superparamagnetic magnetite nanoparticles and their intracellular uptakeBiomaterials23200215531561
   PubMed Web of Science ®Google Scholar
• Y.PanY.J.LiH.Y.ZhaoJ.M.ZhengH.XuG.Weiet al.Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivoInt J Pharm2492002139147
   PubMed Web of Science ®Google Scholar
• H.BassionyS.SabetT.A.Salah El-DinM.M.MohamedA.A.El-Ghoret al.Magnetite nanoparticles inhibit tumor growth and upregulate the expression of p53/p16 in Ehrlich solid carcinoma bearing micePloS One92014e111960
   Web of Science ®Google Scholar
• A.BozecA.RuffionM.DecaussinJ.AndreM.DevonecM.Benahmedet al.Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasiaJ Clin Endocrinol Metab9020051725
   Web of Science ®Google Scholar
• E.C.StuartM.J.ScandlynR.J.RosengrenRole of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancerLife Sci79200623292336
   PubMed Web of Science ®Google Scholar
• T.BorgovanJ.P.BellistriK.N.SlackL.KopelovichM.DesaiA.K.JoeInhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenonE J Exp Ther Oncol82009129144
   PubMedGoogle Scholar
• M.ShimizuA.DeguchiJ.T.LimH.MoriwakiL.KopelovichI.B.Weinstein(−)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cellsClin Cancer Res11200527352746
   PubMed Web of Science ®Google Scholar
• T.MiyashitaS.KrajewskiM.KrajewskaH.G.WangH.K.LinD.A.Liebermannet al.Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivoOncogene9199417991805
   PubMed Web of Science ®Google Scholar
• W.Y.FuJ.P.ChenX.M.WangL.H.XuAltered expression of p53, Bcl-2 and Bax induced by microcystin-LR in vivo and in vitroToxicon462005171177
   PubMed Web of Science ®Google Scholar
• G.I.EvanK.H.VousdenProliferation, cell cycle and apoptosis in cancerNature41168352001342348
   PubMed Web of Science ®Google Scholar
• P.RoyN.NigamJ.GeorgeS.SrivastavaY.ShuklaInduction of apoptosis by tea polyphenols mediated through mitochondrial cell death pathway in mouse skin tumorsCancer Biol Ther8200912811287
   PubMed Web of Science ®Google Scholar
• M.H.LeeD.W.HanS.H.HyonJ.C.ParkApoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-kappaBApoptosis1620117585
   PubMed Web of Science ®Google Scholar
• A.M.RoyM.S.BaligaS.K.KatiyarEpigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activationMol Cancer Ther4120058190
   PubMed Web of Science ®Google Scholar
• J.W.GuK.L.MakeyK.B.TuckerE.ChincharX.MaoI.Peiet al.EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1alpha and NFkappaB, and VEGF expressionVasc cell520139
   PubMedGoogle Scholar
• T.KondoT.OhtaK.IguraY.HaraK.KajiTea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor bindingCancer Lett1802002139144
   PubMed Web of Science ®Google Scholar
• S.LamyD.GingrasR.BeliveauGreen tea catechins inhibit vascular endothelial growth factor receptor phosphorylationCancer Res6222002381385
   PubMed Web of Science ®Google Scholar
• Y.K.LeeN.D.BoneA.K.StregeT.D.ShanafeltD.F.JelinekN.E.KayVEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemiaBlood1042004788794
   PubMed Web of Science ®Google Scholar
• L.BaloghS.S.NigavekarB.M.NairW.LesniakC.ZhangL.Y.Sunget al.Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor modelsNanomedicine32007281296
   PubMed Web of Science ®Google Scholar
• L.ZhangF.X.GuJ.M.ChanA.Z.WangR.S.LangerO.C.FarokhzadNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther832008761769
   PubMed Web of Science ®Google Scholar
• Y.KatoH.OnishiY.MachidaApplication of chitin and chitosan derivatives in the pharmaceutical fieldCurr Pharm Biotechnol42003303309
   PubMedGoogle Scholar
• W.R.ChenM.KorbelikK.E.BartelsH.LiuJ.SunR.E.NordquistEnhancement of laser cancer treatment by a chitosan-derived immunoadjuvantPhotochem Photobiol812005190195
   PubMed Web of Science ®Google Scholar
• J.LiangF.LiY.FangW.YangX.AnL.Zhaoet al.Cytotoxicity and apoptotic effects of tea polyphenol-loaded chitosan nanoparticles on human hepatoma HepG2 cellsMater Sci Eng C Mater Biol Appl362014713
   PubMed Web of Science ®Google Scholar